These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 768503)

  • 1. Use of dimethylmyleran in adoptive chemoimmunotherapy of two murine leukemias.
    Einstein AB; Cheever MA; Fefer A
    J Natl Cancer Inst; 1976 Mar; 56(3):609-13. PubMed ID: 768503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.
    Berenson JR; Einstein AB; Fefer A
    J Immunol; 1975 Jul; 115(1):234-8. PubMed ID: 1080165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for syngeneic adoptive chemoimmunotherapy of murine leukemias.
    Fefer A; Einstein AB; Cheever MA; Berenson JR
    Ann N Y Acad Sci; 1976; 276():573-83. PubMed ID: 1088388
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1980 Aug; 125(2):711-4. PubMed ID: 6156213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA; Peace DJ; Klarnet JP; Kern DE; Greenberg PD; Cheever MA
    J Immunol; 1986 Dec; 137(11):3675-80. PubMed ID: 3491145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of leukemia by nonimmune syngeneic spleen cells.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1980 May; 124(5):2137-42. PubMed ID: 7365249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
    Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
    Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
    Greenberg PD; Cheever MA; Fefer A
    J Exp Med; 1981 Sep; 154(3):952-63. PubMed ID: 6974221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: effect of culture duration on therapeutic efficacy.
    Cheever MA; Greenberg PD; Fefer A
    J Natl Cancer Inst; 1981 Jul; 67(1):169-73. PubMed ID: 6942187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of murine tumors with lethal doses of dimethylmyleran and autologous bone marrow.
    Floersheim GL
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):905-12. PubMed ID: 7035181
    [No Abstract]   [Full Text] [Related]  

  • 15. Solubilized TSTA and the major viral structural proteins, gp70 and p30, in the immune response to murine leukemias induced by Friend and Rauscher virus.
    Rogers MJ; Law LW; Appella E; Oroszlan S; Ting CC
    Int J Cancer; 1977 Aug; 20(2):303-8. PubMed ID: 892937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.
    Schäfer W; Schwarz H; Thiel HJ; Wecker E; Bolognesi DP
    Virology; 1976 Dec; 75(2):401-18. PubMed ID: 795137
    [No Abstract]   [Full Text] [Related]  

  • 17. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dimethylmyleran on cell-mediated immunity to a tumor allograft.
    Einstein AB; Fefer A
    J Natl Cancer Inst; 1975 Nov; 55(5):1143-6. PubMed ID: 1206739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation after lethal chemotherapy in "nude" mice.
    Stinner G; Floersheim GL
    Transplantation; 1977 Sep; 24(3):218-22. PubMed ID: 339432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
    Rosenstein M; Rosenberg SA
    J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.